BCM
TSVT

Bridgeway Capital Management’s 2seventy bio TSVT Stock Holding History

Bridgeway Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-132,400
Closed -$389K – 1254
2024
Q4 		$389K Sell
132,400
-4,300
-3% -$17.6K 0.01% 869
2024
Q3 		$645K Buy
136,700
+25,000
+22% +$113K 0.01% 801
2024
Q2 		$430K Buy
111,700
+15,000
+16% +$67.6K 0.01% 891
2024
Q1 		$517K Hold
96,700
– – 0.01% 915
2023
Q4 		$413K Buy
+96,700
New +$297K 0.01% 987

Other funds holding TSVT

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bridgeway Capital Management's TSVT Position: Q1 2025 in Review

Bridgeway Capital Management sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 132,400 shares — an estimated $389K sold.

Bridgeway Capital Management first reported a position in TSVT in Q4 2023 and held it in 5 quarters. The position peaked at $645K in Q3 2024. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Bridgeway Capital Management reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 132,400 2seventy bio shares in Q1 2025, an estimated $389K.
  • Bridgeway Capital Management first reported a position in 2seventy bio in Q4 2023 and held it in 5 quarters.
  • Bridgeway Capital Management's 2seventy bio position peaked at $645K in Q3 2024.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.